Twist Bioscience Corp Quarterly Share-based Payment Arrangement, Expense in USD from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Twist Bioscience Corp quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q4 2017 to Q3 2024.
  • Twist Bioscience Corp Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $12.3M, a 5.12% increase year-over-year.
  • Twist Bioscience Corp Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $50.9M, a 68.2% increase year-over-year.
  • Twist Bioscience Corp annual Share-based Payment Arrangement, Expense for 2024 was $50.9M, a 68.2% increase from 2023.
  • Twist Bioscience Corp annual Share-based Payment Arrangement, Expense for 2023 was $30.3M, a 61.7% decline from 2022.
  • Twist Bioscience Corp annual Share-based Payment Arrangement, Expense for 2022 was $79M, a 114% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $50.9M $12.3M +$601K +5.12% Jul 1, 2024 Sep 30, 2024 10-K 2024-11-18
Q2 2024 $50.3M $13.7M +$3.14M +29.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $47.2M $13.8M +$3.57M +34.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $43.6M $11M +$13.3M Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-02
Q3 2023 $30.3M $11.7M -$7.02M -37.4% Jul 1, 2023 Sep 30, 2023 10-K 2024-11-18
Q2 2023 $37.3M $10.6M -$9.26M -46.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 $46.6M $10.3M -$12.1M -54.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $58.6M -$2.33M -$20.4M -113% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-02
Q3 2022 $79M $18.8M +$9.52M +103% Jul 1, 2022 Sep 30, 2022 10-K 2024-11-18
Q2 2022 $69.5M $19.9M +$10.7M +116% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $58.8M $22.3M +$10.8M +93.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $48M $18.1M +$11M +157% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-07
Q3 2021 $37M $9.25M +$4.12M +80.3% Jul 1, 2021 Sep 30, 2021 10-K 2023-11-21
Q2 2021 $32.9M $9.18M +$5.1M +125% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $27.8M $11.6M +$7.36M +175% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $20.4M $7.02M +$3.33M +89.9% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-09
Q3 2020 $17.1M $5.13M +$1.77M +52.5% Jul 1, 2020 Sep 30, 2020 10-K/A 2023-06-05
Q2 2020 $15.3M $4.07M +$1.04M +34.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $14.3M $4.2M +$1.29M +44.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $13M $3.7M +$1.83M +98.3% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-09
Q3 2019 $11.2M $3.36M +$2.28M +210% Jul 1, 2019 Sep 30, 2019 10-K 2021-11-23
Q2 2019 $8.89M $3.03M +$2.43M +403% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $6.46M $2.91M +$2.18M +296% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $4.29M $1.86M +$1.33M +248% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-10
Q3 2018 $2.96M $1.09M Jul 1, 2018 Sep 30, 2018 10-K 2020-11-27
Q2 2018 $603K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $736K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $536K Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.